Clues to quality of journals
Open Access Policy of Helmholtz Association 2016
CC Licencences
Publication Metrics
Home
Deutsch
Advanced Search
Browse by ...
Publication overview
Statistics (last 5 years)
OA Publications
Submit Publication
Import publication from...
Report missing publication
Contact persons
Help
Text
Endnote (RIS)
BibTeX
Postprint
DOI
PMC
 |
Open Access Green |
as soon as is submitted to ZB.
The ubiquitin proteasome system as a potential therapeutic target for systemic sclerosis.
Transl. Res., DOI: 10.1016/j.trsl.2018.03.003 (2018)
The present review aims to summarize available knowledge on the role of the ubiquitin-proteasome system (UPS) in the pathogenesis of scleroderma and scleroderma-related disease mechanisms. This will provide the reader with a more mechanistic understanding of disease pathogenesis and help to identify putative novel targets within the UPS for potential therapeutic intervention. Because of the heterogenous manifestations of scleroderma, we will primarily focus on conserved mechanisms that are involved in the development of lung scleroderma phenotypes.
Impact Factor
Scopus SNIP
Scopus
Cited By
Cited By
Altmetric
4.880
1.213
8
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Review
Language
english
Publication Year
2018
HGF-reported in Year
2018
ISSN (print) / ISBN
1931-5244
e-ISSN
1878-1810
Journal
Translational research
Publisher
Elsevier
Publishing Place
New York, NY
Reviewing status
Peer reviewed
Institute(s)
Institute of Lung Health and Immunity (LHI)
POF-Topic(s)
30202 - Environmental Health
Research field(s)
Lung Research
PSP Element(s)
G-501600-004
Scopus ID
85046716791
PubMed ID
29702079
Erfassungsdatum
2018-06-25